Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients

NCT00402116 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Glioblastoma Multiforme
Gliosarcoma

Interventions

DRUG: enzastaurin
DRUG: temozolomide
RADIATION: radiation therapy

Sponsor

Eli Lilly and Company

Collaborators

[object Object]